COMPOUNDINGFINDERManage supplier listing
Two layers. (1) A compounded-medication price index and request-level quote dataset: competing quotes collected from licensed US 503A/503B compounding pharmacies per prescription request, structured on strength, dosage form, quantity, unit of measure (per vial, per ampule, per dose schedule), total volume per sterile prep, sterile vs non-sterile preparation, ingredient sourcing, pharmacy location and state, shipping vs pickup, one-off vs ongoing maintenance fill, and licence/PCAB/503B registration status. (2) A regulatory-status reference layer tracking which compounded medications remain legally compoundable under Section 503A after the FDA declared the semaglutide and tirzepatide shortages resolved in late 2024, with the documented clinical-eligibility reasons that still permit compounding (excipient allergy to polysorbate/benzyl alcohol/phenol, non-commercial strengths for titration or tapering protocols)
Your sourcing agent asks Compoundingfinder and files the sample in your catalog — private to you.
Universe, instruments and categories.
Compoundingfinder has not added their own details yet. Not yet on file: